Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...
Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in ...
“Comprehensive genomic analyses of tumor DNA indicate that they originate from liver cells damaged by MASH, emphasizing a direct link between diet-induced DNA damage and the development of ...
For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study May Proceed” letter from the FDA. From “Boy Meets World” actress Danielle ...
A YOUNG woman has been declared cancer-free after undergoing Britain’s first liver transplant for advanced bowel cancer. Bianca Perea, a 32-year-old trainee lawyer from Manchester, was given the ...
Primary liver cancer, with 906,000 new cases, ranks sixth in growth among malignant tumors. Additionally, with 830,000 deaths, it ranks third in terms of mortality (Sung et al., 2021). Hepatocellular ...